Literature DB >> 9885776

The role of adhesion molecules in atherosclerosis.

M C Chia1.   

Abstract

The progression of atherosclerosis is currently believed to involve the interaction of monocytes with the vascular endothelium. Within the last decade, the cell-surface proteins thought to control these interactions have been investigated. This review seeks to describe the nature of these interactions through what are known as adhesion molecules and their role in atherogenesis. It begins with the stages of atherogenesis from the movement of the monocyte to the endothelium, followed by the migration of smooth muscle cells from the media to the intima, and subsequently to the later stages of fibrofatty plaque formation and potential complications due to thrombosis and/or plaque fissure and embolism. The different structural classifications of the adhesion molecules, such as integrins, cadherins, selectins, and members of the immunoglobulin gene superfamily, are outlined, and interaction of binding domains are highlighted. The vascular endothelium and the basic role of adhesion molecules in dysfunction are considered. Discussion of the role of adhesion molecules in atherogenesis focuses on interactions of the endothelium, monocytes, and leukocytes, as well as the influences of cytokines, oxidized low-density lipoproteins, and genetic determinants. Finally, epidemiological risk factors associated with atherosclerosis such as hypertension and dyslipidemia are considered in light of their effects on adhesion molecule expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9885776     DOI: 10.1080/10408369891234282

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  8 in total

1.  The effect of short-term, high glucose concentration on endothelial cells and leukocytes in a 3D in vitro human vascular tissue model.

Authors:  H Gappa-Fahlenkamp; A S Shukla
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-01-28       Impact factor: 2.416

Review 2.  Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis.

Authors:  Khosrow Khodabandehlou; Jacqueline J Masehi-Lano; Christopher Poon; Jonathan Wang; Eun Ji Chung
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

3.  Nicotine-mediated induction of E-selectin in aortic endothelial cells requires Src kinase and E2F1 transcriptional activity.

Authors:  Vignesh Alamanda; Sandeep Singh; Nicholas J Lawrence; Srikumar P Chellappan
Journal:  Biochem Biophys Res Commun       Date:  2012-01-03       Impact factor: 3.575

4.  Coronary heart disease: Significance of liver X receptor α genomics.

Authors:  Vivek Priy Dave; Deepak Kaul
Journal:  World J Cardiol       Date:  2010-06-26

5.  Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p.

Authors:  A Broisat; L M Riou; V Ardisson; D Boturyn; P Dumy; D Fagret; C Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-12       Impact factor: 10.057

6.  Genetic copy number variants in myocardial infarction patients with hyperlipidemia.

Authors:  Wei-Chung Shia; Tien-Hsiung Ku; Yu-Ming Tsao; Chien-Hsun Hsia; Yung-Ming Chang; Ching-Hui Huang; Yeh-Ching Chung; Shih-Lan Hsu; Kae-Woei Liang; Fang-Rong Hsu
Journal:  BMC Genomics       Date:  2011-11-30       Impact factor: 3.969

7.  FAM3B mediates high glucose-induced vascular smooth muscle cell proliferation and migration via inhibition of miR-322-5p.

Authors:  Wenxiang Zhang; Siyu Chen; Zhao Zhang; Chen Wang; Chang Liu
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

8.  Systemic deficiency of vitronectin is associated with aortic inflammation and plaque progression in ApoE-Knockout mice.

Authors:  Devasmita Chakravarty; Aleepta Guha Ray; Vivek Chander; Ulaganathan Mabalirajan; Prakash Chandra Mondal; Khawer N Siddiqui; Bishnu Prasad Sinha; Aditya Konar; Arun Bandyopadhyay
Journal:  FASEB Bioadv       Date:  2021-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.